Surgery Websites
Transplant Surgery »  Meet the Team »  Emeritus Faculty »  Linda Ferrell, M.D.
Linda D. Ferrell, MD

Linda D. Ferrell, MD

Emeritus Professor
Departments of Pathology & Laboratory Medicine 


Contact Information

Phone:415-353-1633/353-1090
Fax: 415-353-1200
Department of Pathology
505 Parnassus Ave., Rm. M590, Box 0102
San Francisco, CA 94143
linda.ferrell@ucsf.edu
Open Popup
  • 1970-74 University of Kansas, Lawrence, KS B.A. Summa cum laude, Microbiology
  • 1974-77 University of Kansas, Kansas City, KS M.D.
  • 1977-79 University of Kansas, Kansas City, KS Resident Pathology
  • 1980-81 University of California, San Francisco Chief Resident/Surgical Pathology Fellow, Pathology
  • American Board of Pathology, Anatomic Pathology
  • Member, UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Medical Center Organ Transplant Program
  • Fatty liver
  • Hepatitis B and C
  • Liver pathology, emphasizing liver transplantation
  • Liver tumors
  • Well-differentiated hepatocellular tumors & vascular lesions

Linda Ferrell, M.D. is a liver pathologist, Professor of Pathology, Vice Chair of Clinical Services, and Director of Surgical Pathology at UCSF. She specializes in the diagnosis of liver disorders such as: benign liver tumors, cirrhosis, hepatitis B, hepatitis C, hepatocellular carcinoma, vascular lesions, metastastic cancer to the liver, liver transplantation, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). She graduated summa cum laude from the University of Kansas, where she also attended medical school and completed her residency. Dr. Ferrell went on to complete her surgical pathology fellowship at the University of California, San Francisco, while concurrently serving as Chief Resident. She has been the recipient of numerous awards, published a large number of articles and book chapters and currently serves as a co-editor on two medical textbooks in her field of expertise. In early 2010 she was elected Vice President of the United States and Canadian Academy of Pathology (USCAP). Information pertaining to her awards and published materials can be found on her Curriculum Vitae.

Dr. Ferrell's research interests are primarily liver pathology, with emphasis on liver transplantation, fatty liver, hepatitis B and C and liver tumors, particularly well-differentiated hepatocellular tumors and vascular lesions. She actively participated in the World Congress' Consensus Groups for the nomenclature of nodules in the liver and recommendations for terminology for hepatic allograft rejection. Dr. Ferrell's studies on liver pathology in recurrent hepatitis C after transplantation and on the diagnosis of dysplastic nodules have been recognized internationally as leading papers ion these topics. She was also involved in a recent evaluation and review of benign liver tumors in coordination with the International Liver Pathology Study Group and the Laennec Society. Her current ongoing studies involve unusual variants of tumors (HCC, vascular, others), vascular malformations in the liver and other markers in well-differentiated hepatocellular tumors.

MOST RECENT PUBLICATIONS FROM A TOTAL OF 229
Publications provided by UCSF Profiles, powered by CTSI.
  1. Wen KW, Rabinovitch PS, Wang D, Mattis AN, Ferrell LD, Choi WT. Utility of DNA flow cytometry in distinguishing between malignant and benign intrahepatic biliary lesions. Virchows Arch. 2020 Apr 15. View in PubMed
  2. Fels Elliott DR, Tavakol M, Lucas CH, Sheahon K, Kakar S, Hameed B, Ferrell LD, Gill RM. Clinicopathological features and outcomes of parenchymal rejection in liver transplant biopsies. Histopathology. 2020 May; 76(6):822-831. View in PubMed
  3. Putra J, Ferrell LD, Gouw ASH, Paradis V, Rishi A, Sempoux C, Balabaud C, Thung SN, Bioulac-Sage P. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon. Mod Pathol. 2020 04; 33(4):665-675. View in PubMed
  4. Joseph NM, Umetsu SE, Shafizadeh N, Ferrell L, Kakar S. Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum. Mod Pathol. 2019 11; 32(11):1627-1636. View in PubMed
  5. Balitzer D, Joseph NM, Ferrell L, Shafizadeh N, Jain D, Zhang X, Yeh M, di Tommaso L, Kakar S. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma. Mod Pathol. 2019 10; 32(10):1486-1494. View in PubMed
  6. View All Publications

 

Site Directory
    X